Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cytomegalovirus immune globulin, intravenous

Known as: CMVIG 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cytomegalovirus immune globulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The impact of CMV prevention on long‐term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database
Snydman DR, Kistler KD, Ulsh P, Bergman GE, Vensak J, Morris J. The impact of CMV prevention on long‐term recipient and graft… Expand
Highly Cited
2008
Highly Cited
2008
CMV‐hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta‐analysis
Abstract.  Objective:  The goal of this meta‐analysis was to investigate the impact of cytomegalovirus hyperimmune globulin… Expand
Highly Cited
2006
Highly Cited
2006
Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection
Background. Anticytomegalovirus (CMV) prophylaxis prevents the acute disease but its impact on subclinical infection and… Expand
Highly Cited
2001
Highly Cited
2001
IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus…
Background. Cytomegalovirus (CMV) disease was previously shown to be unaltered by a 28-day course of ganciclovir compared with… Expand
Review
2000
Review
2000
Management of cytomegalovirus infection after liver transplantation
Abstract Cyromegalovirus (CMV) is a ubiquitous herpesvirus that, together with human herpesvirus type 6 (HHV- 6) and HHV- 7… Expand
Highly Cited
1997
Highly Cited
1997
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam…
PURPOSE To assess impact of cytomegalovirus (CMV) donor-recipient serostatus, infection, or disease on development of invasive… Expand
Highly Cited
1997
Highly Cited
1997
Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Cytomegalovirus (CMV) causes considerable morbidity and mortality in orthotopic liver transplant (OLT) recipients. Several… Expand
1995
1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates
We undertook a randomized, placebo‐controlled, double blind trial of cytomegalovirus (CMV) immunoglobulin (CMVIG) for prevention… Expand
1993
1993
Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.
 
Review
1993
Review
1993
New developments in cytomegalovirus prevention and management.
The use of CMVIG, approved in 1990 for prophylactic administration in seronegative recipients of kidneys from seropositive donors… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE